Zoonotic & Vector-Borne Diseases

Researchers have found that the Zika virus is able to survive for at least eight hours on hard, non-porous surfaces.

The pharmaceutical giant, Bayer, began enrolling participants in a Phase III clinical trial in January 2016 with hopes to find appropriate dosing of Nifurtimoxin for children and newborns.

As health officials investigate a recent outbreak of acute flaccid myelitis in Washington State, more cases of the rare condition have appeared in other Western states; questions about the cause remain unanswered.

A recent study finds that when it comes to mosquito-borne outbreaks, in this case, Chikungunya, infections originate around the home with women more likely to become infected than men.

The results of an election poll question on conducting an effectiveness trial using genetically modified mosquitoes to combat the Zika virus revealed mixed feelings among Florida natives.

Human trials are currently underway for a potential candidate vaccine for the Zika virus and a novel treatment approach has shown promise in mice.

The Centers for Disease Control and Prevention has issued Zika guidance designed to bolster infection control and limit exposure to clinicians and other caregivers.

As travel-related Zika virus numbers continue to grow, New York City bolsters its Zika Preparedness and Response Action Plan.

Researchers have noted four other features unusual for babies born with congenital infections due to Zika virus infection.

A new study found that Lyme disease cases in the Western United States could rise as a result of weather changes caused by El Niño.

Speakers at the annual meeting of the Infectious Diseases Society of America discussed infectious disease epidemics across the globe.

The first case of Mayaro virus has been reported in Haiti.

A new study has found that Zika virus impacts fertility in male mice.

At the annual meeting of Infectious Diseases Society of America, researchers revealed that in addition to microcephaly, other neurological consequences of Zika virus are being recognized.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, explains what Powassan virus is.

Researchers say Morgellons disease is associated with Lyme disease, and the colorful filaments protruding from the skin are comprised of keratin and collagen.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses the prevalence of Zika virus infections in New York City.

Zika has reached Australia and authorities are taking preventive measures to prevent a large-scale outbreak.

Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.

The nation’s top public health officials believes the disease is destined to spread across the United States in the coming months.

Despite public outcry, experts agree that vector-control methods are still the most effective ways to fight the spread of the Zika virus.

New cases of Zika are impacting Florida’s “Little Haiti” neighborhood.

Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses if Lyme disease poses a bigger threat than Zika virus in New Jersey.

The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.

With social media serving as a news source to so many, researchers from the Medical College of Wisconsin and the Tulane University School of Medicine studied how Facebook users are talking about the Zika virus.

New studies on the Zika virus have revealed how long the virus may stay in the vaginal tract, as UK researchers have mapped the first complete Zika virus genome derived from semen.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if the public should be concerned by avian influenza.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains how to combat anti-vaccine trends.